Questionnaire for quality of life in interstitial lung disease
Part of Lungs & breathing clinical trials.
This study is testing a questionnaire called the King's Brief Interstitial Lung Disease Questionnaire to see how well it measures quality of life in people with interstitial lung disease. You will be asked to fill out the questionnaire, which may help doctors better understand how the disease affects daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with interstitial lung disease by a rheumatologist.
- You must be 18 years of age or older.
- You must be willing to participate in the study.
- You must not have a neurological disease (like Parkinson's or multiple sclerosis) or an orthopedic problem that affects your ability to move or function.
- You must not have had any orthopedic surgery in the last year.
- You must be able to speak and understand Turkish fluently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to develop a new questionnaire to measure how pulmonary arterial hypertension affects daily life. It may help patients and doctors better understand the condition's impact.
This study tests a home-based program of breathing exercises and physical activity for people with interstitial lung disease, aiming to improve breathlessness and daily function.
This study uses artificial intelligence to help doctors better understand and care for people with interstitial lung disease. You'll fill out a simple questionnaire to help improve how the clinic works.
This study looks at how chronic respiratory failure affects day-to-day quality of life. It enrolls people who use breathing support at home or in care, and may help clinicians understand what support works best for patients’ daily living.
This study asks people with inflammatory bowel disease to fill out questionnaires about their quality of life. It aims to learn how the condition affects daily living and well-being.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
Hear when a new Interstitial Lung Disease Due to Systemic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.